INTRODUCTION AND OBJECTIVES:
Numerous studies have examined the relationship between male infertility and men 0 s health but most have not investigated specific causes of infertility and their health impact. Here we examine the relationship between general male health and sperm aneuploidy.
METHODS: We used the Charlson Co-Morbidity Index (CCI) to assess and compare the health status of men with abnormal sperm aneuploidy to five groups of men who received care at an academic infertility clinic: men with normal sperm ploidy (normal FISH), men with genetic abnormalities that may cause infertility (genetic infertile), men presenting for infertility with varicocele (varicocele), men with idiopathic infertility (idiopathic) and proven-fertile men. Sperm ploidy was assessed using fluorescence in situ hybridization (FISH). Genetic infertile men had proven Y chromosome microdeletions or abnormal karyotype. CCI for men with sperm FISH results was completed via telephone survey and CCI for genetic infertile men was extracted from intake forms. Men who were diagnosed with a varicocele or idiopathic infertility had not conceived after 12 months. Men with varicoceles, men with idiopathic infertility, and fertile controls completed the CCI in clinic. Fertile controls included men who presented for vasectomy and had fathered a child in the past 5 years.
RESULTS: 402 men were included in this analysis: 92 with an abnormal sperm FISH results, 7 with a normal sperm FISH test, 49 genetic infertile men, 85 men with idiopathic infertility, 86 infertile men with varicocele, and 83 fertile controls. Mean age, semen density, and CCI of all groups are described in Table 1 . Of note, malignancy was common in our cohort, exceeding rates in the SEER database for comparable age (Table 1) . Controlling for age, we explored infertility groups as a predictor of elevated CCI score, and found that only men with abnormal sperm FISH (p¼0.002) had increased risk of a higher CCI score. Age also increased the risk for a higher CCI score, with each additional year raising the CCI by 0.0117 points (p¼0.009).
CONCLUSIONS: Men with elevated sperm aneuploidy have nearly double the prevalence of general health issues, particularly malignancy, when compared with men with infertility of other etiologies. These findings further support the relationship between genetic causes of male infertility and general health. We found no difference in the fragmentation between groups of patients with Toxic habits (Alcohol and Tobacco) and without them. Of patients exposed to agrochemicals, 45.3% showed increased DNA fragmentation. A significant and negative correlation was found between TUNEL and concentration / ml, total concentration of the ejaculate; total motility; rapid progressive motility; morphology and nuclear maturity. (P <0.0001).
CONCLUSIONS: Conclusion: According to our results, we observed a significant negative correlation between TUNEL and seminal parameters. In agreement with other works we find that the exposure to environmental agrochemicals would produce a deleterious effect on the fragmentation of the DNA. Taking into account that an increased TUNEL was found in 22.4% of Normospermic patients, we emphasized the usefulness of this test to more fully study the fertility of the patients and thus to be able to take therapeutic measures that favor reproductive success. METHODS: Demographic, clinical and laboratory data a cohort of primary infertile men were analyzed. Comorbidities were scored with the Charlson Comorbidity Index (CCI; categorized 0 vs. >¼1). Semen analysis was based on 2010 WHO reference criteria. Serum hormones and sperm DFI [sperm chromatin structure assay (SCSA); DFI <30% was defined as non-pathologic] were measured in every patient. Smoking status was categorized as: no current smokers (Group 1); moderate smokers (<10 cigarettes/day; Group 2); and, heavy smokers (>10 cigarettes/day; Group 3). Descriptive statistics and logistic regression models tested the association between smoking status and clinical, seminal and hormonal characteristics in our cohort.
RESULTS: Overall, 132 (69.8%), 30 (15.9%), and 27 (14.3%) patients belonged to Group 1, 2 and 3, respectively. Groups did not differ in terms of hormonal milieu. Of all, a pathologic DFI was found in 104 (55%) patients. Smokers (Groups 2+3) more frequently reported a CCI>¼1 (p¼0.02), oligozoospermia (p¼0.04), asthenozoospermia (p¼0.003), and a pathologic DFI (p¼0.04) compared to non-smokers. At Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e461
